We strive to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies. To accomplish this mission, we’re dedicated to working with everyone in Washington, DC, and across the country.

Eligible patients are provided with cost-free medications, or, in some cases, subsidy relief is given for high health insurance co-payments. See website for list of drugs.